Latest News & Features
Europe
The Court of Appeal for England and Wales has upheld the Patent Court’s decision that Teva Pharmaceutical Industries’ UK patent 762,888, relating to the multiple sclerosis drug Copaxone, is valid. 1 August 2013
Americas
Danish firm Bavarian Nordic has a portfolio of patents for vaccines and cancer treatments, but likes to keep some of its cards close to its chest, as LSIPR finds out. 31 July 2013
Europe
At some offices, the passage of a patent through the system is not quite as fast as applicants might hope—and at others it may be quicker than they would like. Matt Smith and Jonathan Wills outline the situation. 31 July 2013
Americas
Gabriel Di Blasi outlines the existing impediments to developing new biotechnology products in Brazil,
and considers recent efforts to improve the situation. 31 July 2013
article
A US court has ruled that an Israeli company’s patent for a multiple sclerosis (MS) drug is invalid, paving the way for rivals to market a generic version. 30 July 2013
Americas
A US court has upheld a decision ruling that a continuation patent filed by a bio-tech company is invalid. 26 July 2013
Americas
The chair of the FTC has said it will continue to challenge pay-for-delay court settlements in the pharmaceutical industry and has hailed a Supreme Court ruling as a victory for consumers. 25 July 2013
Americas
A white paper suggests that patent case settlements between originator pharmaceutical companies and their generic competitors may be beneficial to drug consumers. 25 July 2013
Americas
The chief legal officer at the United States Patent and Trademark Office has announced he will be leaving. 24 July 2013
Americas
Senator Patrick Leahy has urged the US National Institutes of Health to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer. 19 July 2013